Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2021 - 11 - 15 save search
Inhibikase Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
Published: 2021-11-15 (Crawled : 23:00) - prnewswire.com
IKT | $2.1 0.19% 52K
|
Health Technology
|
| O: -0.78%
H: 0.29%
C: -5.58%
financial results results
CymaBay Therapeutics Long-term Open Label Study Finds Treatment with Seladelpar for Two Years Improves Key Liver Biomarkers in Patients with PBC
Published: 2021-11-15 (Crawled : 20:00) - biospace.com/
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 0.0%
H: 3.17%
C: -2.72%
treatment liver biomarkers
Su Young Kim, M.D., Ph.D.
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
Michael Mischke-Reeds
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
Seema P. Rogers, M.S.
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
ema
Kim Trahan
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
Ena Wang, M.D., M.S.
Published: 2021-11-15 (Crawled : 20:00) - nurixtx.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.34%
H: 0.92%
C: -1.51%
618RJ, Scientist, Potency and Functional Characterization
Published: 2021-11-15 (Crawled : 18:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.97%
H: 0.83%
C: -4.72%
619RL, Senior Manager / Manager, Quality Control
Published: 2021-11-15 (Crawled : 18:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.97%
H: 0.83%
C: -4.72%
620FB, Quality Control Associate III-I
Published: 2021-11-15 (Crawled : 18:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.97%
H: 0.83%
C: -4.72%
Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer
Published: 2021-11-15 (Crawled : 17:00) - biospace.com/
KZIA | $0.379 9.47% 8.65% 300K
|
Health Technology
|
| O: -1.03%
H: 1.92%
C: -2.53%
CLRB | $3.02 -0.66% -0.66% 810K
|
Health Technology
|
| O: 1.05%
H: 0.55%
C: -3.62%
therapeutics
Qualigen Therapeutics, Inc. Reports Third Quarter 2021 Financial Results
Published: 2021-11-15 (Crawled : 16:00) - biospace.com/
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -0.93%
financial results results therapeutics
Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 at the American Heart Association 2021 Scientific Sessions
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
KROS | $58.345 -1.03% -1.04% 350K
|
Health Technology
|
| O: 0.19%
H: 0.52%
C: -0.73%
preclinical heart results pre-clinical
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M
|
Health Technology
|
| O: -0.39%
H: 1.4%
C: -4.96%
covid disease antibody iot
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-15 (Crawled : 15:00) - globenewswire.com
BLPH | $0.0571 -45.37% 15M
|
Health Technology
|
| O: 3.82%
H: 4.29%
C: 3.99%
financial results results
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021
Published: 2021-11-15 (Crawled : 15:00) - globenewswire.com
SMMT A | $3.51 0.0% 1.7M
|
Health Technology
|
| O: -2.59%
H: 2.85%
C: -1.14%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -3.06%
H: 2.71%
C: 0.3%
financial results results
Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-15 (Crawled : 15:00) - globenewswire.com
ATOS | $1.37 -3.52% -3.65% 1.2M
|
Health Technology
|
| O: -0.38%
H: 4.17%
C: -2.65%
financial results results
Alchemab Therapeutics Appoints Young T. Kwon, PhD as Chief Financial and Operating Officer
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.36%
H: 0.0%
C: 0.0%
ema
Nektar Therapeutics Strengthens Board of Directors with Appointment of Diana M. Brainard, M.D.
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -3.06%
H: 2.71%
C: 0.3%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
ALVR | $0.7505 1.13% 1.12% 340K
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: -2.77%
Akebia Therapeutics to Present at Jefferies London Healthcare Conference
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
AKBA | $1.36 -2.16% -2.21% 2.9M
|
Health Technology
|
| O: -2.36%
H: 1.04%
C: -0.69%
conference therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.